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Abstract
We report that Binder of Arl Two (BART) plays a role in inhibiting cell invasion by regulating the activity of the Rho
small guanosine triphosphatase protein Rac1 in pancreatic cancer cells. BART was originally identified as a binding
partner of ADP-ribosylation factor-like 2, a small G protein implicated as a regulator of microtubule dynamics and
folding. BART interacts with active forms of Rac1, and the BART-Rac1 complex localizes at the leading edges of
migrating cancer cells. Suppression of BART increases active Rac1, thereby increasing cell invasion. Treatment of
pancreatic cancer cells in which BART is stably knocked down with a Rac1 inhibitor decreases invasiveness. Thus,
BART-dependent inhibition of cell invasion is likely associated with decreased active Rac1. Suppression of BART
induces membrane ruffling and lamellipodial protrusion and increases peripheral actin structures in membrane
ruffles at the edges of lamellipodia. The Rac1 inhibitor inhibits the lamellipodia formation that is stimulated by
suppression of BART. Our results imply that BART regulates actin-cytoskeleton rearrangements at membrane
ruffles through modulation of the activity of Rac1, which, in turn, inhibits pancreatic cancer cell invasion.
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Introduction
BART is a soluble 19-kDa protein that was originally purified from
bovine brain and identified as a binding partner of the small GTP-
binding protein (G protein) ADP-ribosylation factor-like 2 (ARL2)
[1]. Small G-ARL proteins lack the biochemical and genetic activities
characteristic of the ADP-ribosylation factor family, despite the 40%
to 60% amino acid sequence identity between ADP-ribosylation
factors and ARLs [2]. ARL2 has been implicated as a regulator of mi-
crotubule dynamics and folding [3], but its function remains largely
unknown. We previously reported that regulation of BART post-
transcriptional modification through intracellular CD24 binding to
G3BP in stress granules contributes to inhibition of invasion and
metastasis of pancreatic ductal adenocarcinoma (PDAC) cells [4].
Further study demonstrated that BART decreases invasiveness of
PDAC cells by inhibiting the ARL2-mediated decrease in the activity
of the small guanosine triphosphatase (GTPase) protein RhoA [5].
The Rho family of GTPases cycle between an active guanosine 5′-
triphosphate (GTP)–bound and inactive guanosine 5′-diphosphate
(GDP)–bound state to control shape, motility, polarity, and behavior
[6]. The Rho members, of which Rac1, Cdc42, and RhoA are the
most commonly studied examples, play critical regulatory roles in sev-
eral key cellular processes such as in the cytoskeletal rearrangement
that underlies changes in cell shape, motility, and polarization [7,8].
Rac1 is activated by platelet-derived growth factor or insulin and
induces the assembly of a meshwork of actin filaments at the cell
periphery, producing lamellipodia and membrane ruffling; Cdc42
induces actin-rich surface protrusions or filopodia, whereas RhoA,
which is activated by extracellular ligands, induces the assembly of
contractile actin-myosin filaments (stress fibers) and associated focal
adhesion complexes [9]. Migratory competence of tumor cells requires
activation of the motile cycle, the first step of which is actin remodeling,
which drives the formation of cell protrusions, defines the direction of
migration, and initiates the growth of the lamellipodium [10]. Because
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BART inhibits PDAC cell invasion by catalyzing GTP/GDP exchange
of RhoA [5], it should be determined whether BART also functions in
regulating the activity of other Rho GTPases.
Other evidence that BART is associated with the regulation of Rho
GTPase activity has been reported. When BART interacts with
ARL2, it affects the transcriptional activity and nuclear retention of
signal transducer and activator of transcription 3 (STAT3), which is
both a cytoplasmic signaling molecule and a nuclear transcription fac-
tor [11]. Recent studies have linked STAT3 to the metastatic progres-
sion of several different cancer types. Studies using mouse embryo
fibroblasts established STAT3 as a component of the Rho GTPase
signaling cascade [12,13]. Although the mechanisms that contribute
to the constitutive activation of STAT3 in cancer invasion and metas-
tasis are currently unclear, BART might contribute to the regulation
of cell migration through the Rho GTPase signaling cascade.
In this study, we report the mechanism by which BART regulates
the level of active Rac1 in PDAC cells. BART directly and predom-
inantly binds to active forms of Rac1 and plays a role in decreasing the
cellular level of active Rac1. BART and Rac1 are recruited to, and
colocalize at, the leading edge of motile PDAC cells. Suppression of
BART by RNA interference (RNAi) strongly enhances cell motility
and invasiveness in PDAC cell systems [4]. The increased invasion
resulting from BART knockdown was significantly abrogated by over-
expression of BART, and treatment of BART RNAi cells with the
Rac1 inhibitor decreased invasive activity. Thus, decreased levels of
active Rac1 due to BART contributes to BART-mediated inhibition
of invasion of PDAC cells. Further investigation suggested that BART
regulation of Rac1 activity in PDAC cells inhibits cell invasion by
restricting surface rearrangements of the actin cytoskeleton.
Materials and Methods
Reagents and Antibodies
The Rac1 inhibitor NSC23766 was obtained from Calbiochem
(San Diego, CA). The RhoGAP Assay Biochem Kit was obtained
from Cytoskeleton (Denver, CO). The rabbit anti-BART antibody
(10090-2-AP) was purchased from ProteinTech (Chicago, IL).
Monoclonal antibodies against Rac1 (610650), Cdc42 (610929),
and β-catenin (610154) were obtained from BD Transduction Labo-
ratory (Palo Alto, CA). Monoclonal antibody against RhoA (26C4)
was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
The rabbit anti–E-cadherin antibody (4065) was obtained from Cell
Signaling (Danvers, MA). The rabbit anti-myc antibody (A14) was
purchased from Santa Cruz Biotechnology.
Cell Culture
The human PDAC cell line S2-013, a subline of SUIT-2, was
obtained from Dr T. Iwamura (Miyazaki Medical College, Miyazaki,
Japan) [14]. The human PDAC cell line PANC-1 was obtained from
the ATCC. Cells were grown in Dulbecco modified Eagle medium
(Gibco-BRL, Carlsbad, CA) supplemented with 10% heat-inactivated
fetal calf serum at 37°C in a humid atmosphere saturated with 5%CO2.
Small Interfering RNA–Expressing Constructs and the
Generation of Stable Cell Lines
The methods used were as previously reported [4].
Affinity Precipitation Using a Glutathione S-transferase–Fused
Rac1 Interactive Binding Domain
The pGEX-6P1 plasmids encoding p21-activated kinase (PAK)–
Cdc42/Rac interactive binding (CRIB) domain or Rhotekin were
kindly provided by Dr K. Johnson (University of Nebraska Medical
Center, Omaha, NE). Glutathione S -transferase (GST)–binding fu-
sion proteins were purified from transformed Escherichia coli using
glutathione-Sepharose beads and were used for affinity precipitation
in GST-pull-down assays to estimate the activity of Rac1, Cdc42,
and RhoA. Equal amounts of protein from each cell lysate that had
been maintained in Dulbecco modified Eagle medium supplemented
with 5% fetal bovine serum were incubated with 8 μg of GST-fusion
protein, and the bound proteins were detected byWestern blot analysis
using anti-Rac1, anti-Cdc42, and anti-RhoA antibodies.
Wound Healing Motility Assay
A wound in the form of a cross was made through confluent cell
monolayers with a plastic pipette tip. Several wound areas were
marked for orientation and were then photographed under phase-
contact microscopy. At set times ranging from 4 to 20 hours in in-
dividual experiments, marked wounds were photographed again, and
the degree of wound closure was quantified. The number of cells that
had migrated into the initially cell-free scratch area was counted.
Matrigel Invasion Assay
A two-chamber invasion assay was used to assess cell invasion (24-
well plates, 8-μm pore size membrane coated with a layer of Matrigel
extracellular matrix proteins; Becton Dickinson, Franklin Lakes, NJ).
Cells (4.0 × 104) were seeded in serum-free medium into the upper
chamber and allowed to invade toward a 5% fetal calf serum chemo-
attractant in the lower chamber. After 20 hours of incubation, the
number of invading cells at the bottom of the membrane was esti-
mated under microscopic observation by counting three independent
visual fields.
In Vivo Binding of BART with Rac1
S2-013 cells were lysed in lysis buffer and immunoprecipitated with
2 μg of anti-BART or anti-Rac1 antibody. To examine the interaction
of endogenous BART with endogenous Rac1, immune complexes
were analyzed by Western blot analysis with anti-BART and anti-
Rac1 antibodies.
Confocal Immunofluorescence Microscopy
Cells were fixed with 4% paraformaldehyde, permeabilized with
0.1% Triton X-100, covered with blocking solution (3% bovine serum
albumin/phosphate-buffered saline), and then incubated with the pri-
mary antibody for 1 hour. Alexa 488 and Alexa 594–conjugated sec-
ondary antibodies (Molecular Probes, Carlsbad, CA) were used with or
without rhodamine-conjugated phalloidin (Cytoskeleton). Each speci-
men was visualized using a Zeiss LSM 510 META microscope (Carl
Zeiss, Gottingen, Germany). To investigate the functional link between
BART and Rac1, 24 hours after transfection of myc-tagged BART-
rescue plasmids into BARTRNAi S2-013 cells, the cells were seeded on
fibronectin-coated glass coverslips and incubated for 3 hours, followed
by immunostaining with the indicated antibodies.
Wound Healing Immunostaining Assay
A wound in the form of a cross was made through the confluent
cell monolayer with a plastic pipette tip, and the cells were then
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allowed to polarize and migrate into the wound. After 4 hours, the cells
were immunostained with the primary antibody and incubated with
fluorophore-conjugated secondary antibodies as described above. Each
specimen was visualized using a Zeiss LSM 510 META microscope.
Inhibition of Endogenous Rac1 by a Rac1-Specific Inhibitor
Cells cultured to 80% confluence were pretreated with the Rac1
inhibitor NSC23766 (100 μM) for 4 hours. After washing, the cells
were analyzed by confocal immunostaining, GST-PAK-CRIB pull-
down, Matrigel invasion, and wound healing assays.
Recombinant BART
The entire coding sequence of BART complementary DNA was
amplified by reverse transcription–polymerase chain reaction. The
product was subsequently inserted into the pIEx-7 Ek/LIC vector
(Novagen, Madison, WI) to produce a fusion protein bearing an
N-terminal 6-histidine tag. Sf9 cells (Novagen) were transiently trans-
fected using the Insect GeneJuice Transfection Reagent (Novagen),
according to the manufacturer’s instructions. Transfected cells were
lysed in CytoBuster Protein Extraction Reagent (Novagen) and centri-
fuged at 15,000g for 15 minutes. The supernatant was mixed with Ni-
NTA His-Bind Resin (Novagen), and the bound proteins were eluted.
Western blot analysis using an anti-BART antibody was performed to
identify the fractions containing BART. The fractions corresponding
to apparently pure proteins were pooled and dialyzed against storage
buffer consisting of 20 mM HEPES (pH 7.4), 20 mM KCl, and
10% glycerol. The samples were stored at −80°C.
GST-Rac1 Binding Assay In Vitro
GST-tagged Rac1 protein (8 μg) attached to glutathione-agarose
beads (Cytoskeleton) was incubated either with GTPγS or with
GDP at a final concentration of 1 mM in 20 μl of reaction buffer
(50 mM HEPES [pH 7.4], 100 mM NaCl, 10 mM MgCl2, 5 mM
EDTA, 1 mM DTT) at 30°C for 15 minutes. The MgCl2 concen-
tration of the buffer was then increased to 50 mM. and 6 μg of
recombinant BART protein was added and incubated at 4°C for
4 hours. GST was used as a control. After the beads were extensively
washed with lysis buffer, the bound proteins were detected by Western
blot analysis using anti-BART and anti-Rac1 antibodies.
GST-Rac1/Rac1N17 Pull-down Assays Using
PDAC Cell Lysates
GST-Rac1 and -Rac1N17 proteins attached to glutathione-agarose
beads were obtained from Cytoskeleton. S2-013 cells were lysed in
lysis buffer, and equal amounts of total lysates were incubated with
8 μg of each GST-fusion protein at 4°C for 1 hour. GST was used
as a control. Western blot analysis with anti-BART antibody was per-
formed to detect coprecipitated BART.
BART-Rescue Construct
The entire coding sequence of the BART complementary DNA
was amplified using reverse transcription–polymerase chain reaction.
The product was subsequently inserted into a pCMV6-Entry vector
(Origene, Rockville, MD) bearing a C-terminal myc-DDK-tag. This
BART-rescue construct was transiently transfected into cells using
FuGENE6 (Roche, Penzberg, Germany).
In Vitro Rho–GTPase-Activating Protein Assay
In vitro GTPase-activating protein (GAP) assays were performed
in triplicate using the RhoGAP Assay Biochem Kit (Cytoskeleton).
His-tagged Rac1 (5 μg; Cytoskeleton) was incubated with recom-
binant BART protein (0.5 μmol) and 200 μM GTP with or with-
out the p50 RhoGAP protein (0.5 μmol; Cytoskeleton) at 37°C for
20 minutes in a reaction mixture (20 μl) containing 25 mM HEPES
(pH 7.4), 100mMNaCl, 2mMMgCl2, and 1mMDTT. GST protein
(0.5 μmol) was used as a negative control for BART. Phosphate gen-
erated by hydrolysis of GTP was measured by adding the CytoPhos
reagent (Cytoskeleton), and the absorbance was read at 650 nm.
Cytosol and Membrane Fractionation
Cells were homogenized in hypotonic buffer (20 mM Tris-HCl
[pH 8.0], 150 mMNaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl
fluoride, and 1 mMNa3VO4) using a Dounce homogenizer and centri-
fuged at 700g for 5 minutes, and the postnuclear supernatant was then
centrifuged at 100,000g for 1 hour. The resulting supernatant was col-
lected and used as the cytosolic fraction. The pellet was resuspended in
hypotonic buffer containing 1%Triton X-100 and incubated on ice for
1 hour. The supernatant component (particulate fraction) was centri-
fuged at 14,000g for 20 minutes. Protein concentrations were deter-
mined with the Bio-Rad protein assay (Hercules, CA) using bovine
serum albumin as a standard.
Statistical Analysis
The significance of differences between groups was determined
using Student’s t test, the Mann-Whitney U test, or Fisher exact test,
as appropriate. P < .05 was considered statistically significant.
Results
BART Decreases the Level of Active Rac1 and Inhibits PDAC
Cell Motility and Invasion
BART expression is suppressed by a vector-based specific short
hairpin small interfering RNA (siRNA) in the PDAC cell lines S2-
013 and PANC-1 that express high levels of endogenous BART
[4]. Knockdown of BART increases retroperitoneal invasion and liver
metastasis of PDAC cells in an orthotopic xenograft model [4]. To
determine the effect of BART depletion on Rac1 activity, we assayed
Rac1 activity of cell lysates by performing a GST-pull-down assay
using a GST-Rac1 interactive binding domain fusion protein (GST-
PAK-CRIB; Figure 1A ). We found that suppression of BART resulted
in an increase in active Rac1 compared with mock-transfected or
scrambled siRNA-transfected cells, suggesting that endogenous BART
is associated with a decrease in the activity of Rac1. The amount of
GTP-Cdc42, a closely related Rho GTPase, was not affected (data
not shown). We next determined the effect of the Rac1 inhibitor
NSC23766 [15] on the cell motility and invasion of control and BART
RNAi S2-013 cells. We confirmed that pretreatment of BART RNAi-
S2-013 cells with the Rac1 inhibitor decreased the level of GTP-Rac1
(Figure 1B). The amounts of GTP-Cdc42 and GTP-RhoA were not
affected (Figure 1B), confirming the specificity of NSC23766. Pretreat-
ment of control and BART RNAi S2-013 cells with the Rac1 inhibitor
significantly inhibited cell motility in a wound healing assay and
Matrigel invasion in a two-chamber assay (Figure 1, C and D, respec-
tively). Importantly, the Rac1 inhibitor decreased cell motility and
invasiveness of BART RNAi S2-013 cells to the levels of the control
cells that had not been pretreated with the Rac1 inhibitor (Figure 1,
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C andD). These results indicate that activated Rac1 plays an important
role in accelerating cell migration and that BART-dependent inhibition
of PDAC cell motility, and invasion is likely to be associated with a
decrease in active Rac1.
BART Binds to Rac1 at Cell Protrusions
To determine whether BART and Rac1 associate in PDAC cells,
endogenous BART and Rac1 were immunoprecipitated from S2-013
cells, followed by immunoblot analysis using anti-BART and anti-
Rac1 antibodies (Figure 2A). This experiment indicated that BART
did coimmunoprecipitate with Rac1 from S2-013 cells. We next
examined the subcellular localization of BART and Rac1 in S2-013
cells using immunofluorescence (Figure 2B). BART and Rac1 coloca-
lized in both the cytoplasm and in lamellipodial-like protrusions. The
latter localization is characteristic of factors that modulate, and are
essential for, cell migration (Figure 2B, arrows). Rac1, Cdc42, and
RhoA are best known as master regulators of the actin cytoskeleton
and promote the formation of lamellipodia, filopodia, and stress
fibers, respectively [6]. We therefore hypothesized that BART is asso-
ciated with the regulation of lamellipodia formation through a de-
crease in the activity of Rac1 and thereby inhibits cell invasion. In
addition, the localization of BART and Rac1 in polarized migrating
Figure 1. BART decreases the activity of Rac1 resulting in inhibition of PDAC cell motility and invasion. (A) The amount of active, GTP-
loaded Rac1 in S2-013 and PANC-1 cells that were mock transfected (Neo-1) or transfected with control, scrambled (Scr-1), or BART
(siBART-1 and 2) siRNA was determined using a GST-PAK-CRIB pull-down assay. Precipitates were examined by Western blot analysis
using an anti-Rac1 antibody. Data are representative of three independent experiments. (B) Two S2-013 clones transfected with siRNA
for BART were pretreated with or without the Rac1 inhibitor (NSC23766), and the amount of active GTP-loaded Rac1 and Cdc42 and
RhoA was analyzed with GST pull-down assays using GST-PAK-CRIB and GST-Rhotekin, respectively. Precipitates were examined by
Western blot analysis using anti-Rac1, anti-Cdc42, and anti-RhoA antibodies. Total levels of Rac1, Cdc42, and RhoA protein were used to
normalize the data. Data are representative of three independent experiments. (C) Confluent control and BART RNAi S2-013 cells treated
as in B were wounded. The number of cells that migrated into an initially cell-free scratch was counted. Cells in four defined areas per
group per experiment were quantified. Data are representative of three independent experiments. Bars, SD; columns, mean. *P < .005,
**P < .001 compared with nontreated cells. (D) Control and BART RNAi S2-013 cells treated as in B were plated on Matrigel invasion
chambers. Invaded cells in four fields per group were counted. Data are representative of three independent experiments. Bars, SD;
columns, mean. *P < .005, **P < .001 compared with nontreated cells.
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S2-013 cells was analyzed using a wound healing immunostaining
assay (Figure 2C ). This assay showed that BART and Rac1 were
recruited to the leading edges during wound healing of S2-013 cells,
indicating that they function interdependently in cell migration.
Cell-cell adhesion can also influence cell motility [16]. On the for-
mation of cell-cell contacts, cells reduce their migration rate and cell
surface protrusion activity and decrease their microtubule and actin-
filament dynamics [17]. Rac has been shown to be important both
upstream and downstream of adherens junction formation, and too
much or too little Rac activity disrupts adherens junctions in cultured
mammalian epithelial cells [18–20]. To determine the effect of Rac1
on cell-cell contact, S2-013 cells were incubated with the Rac1 inhib-
itor NSC23766, and adherens junctions were analyzed by immuno-
fluorescence using anti–E-cadherin and anti–β-catenin antibodies
(Figure W1A ). We found that the Rac1 inhibitor did not affect the
presence of these junction proteins at regions of cell-cell contact of
S2-013 cells. However, interestingly, the level of these junction proteins
at the cell-cell contacts of S2-013 cells was significantly reduced in
BART RNAi cells compared with control cells (Figure W1B ), indicat-
ing a decreased peripheral localization of junction proteins in these cells
that resulted in adherens junctions with decreased stability. These
results suggest that, although BART plays a role in inhibiting cell inva-
sion through decreasing active Rac1 and colocalizes withRac1 at the lead-
ing edges of migrating cells, BART also functions in regulation of the
Figure 2. BART binds to Rac1 at the leading edges of migrating cells. (A) Immunoprecipitation of endogenous BART or Rac1 from S2-013
cells. Anti-BART or anti-Rac1 immunoprecipitates were examined by Western blot analysis using anti-BART and anti-Rac1 antibodies.
Rabbit IgG and mouse IgG monoclonal antibodies were used as isotype controls for anti-BART and anti-Rac1 antibodies, respectively.
Data are representative of three independent experiments. (B) Immunocytochemical staining of S2-013 cells using anti-BART (green) and
anti-Rac1 (red) antibodies. Arrow indicates colocalized BART and Rac1 in lamellipodial-like protrusions; blue, DAPI staining. Bar, 10 μm.
(C) Confluent S2-013 cells were wounded. After 4 hours, the cells were immunostained using anti-BART (green) and anti-Rac1 (red) anti-
bodies. Arrows indicate colocalized BART and Rac1 at the leading edge; blue, DAPI staining. Bar, 10 μm.
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stability of cell-cell contacts in a Rac1-independent manner. The mech-
anism by which BART influences cell-cell contacts is still unknown.
BART Binds to an Active Form of Rac1
To determine the activation state of the Rac1 that binds to BART,
GST-tagged Rac1 was incubated with GDP or GTPγS and then used
in in vitro pull-down experiments with the recombinant BART pro-
tein (Figure 3A). A significant amount of the constitutively active
GTPγS-Rac1 bound to BART compared with the inactive GDP-
Rac1 form, which only weakly interacted with BART. Further pull-
down experiments were carried out to confirm this interaction in
PDAC cells (Figure 3, B and C ). Binding of endogenous BART to
GST-tagged wild-type Rac1, a dominant-negative mutant Rac1 form,
Rac1N17, or the CRIB motif that interacts with GTP-Rac1, was
assayed by incubation of these GST proteins with S2-013 cell lysates,
followed by a GST-pull-down assay and Western blot analysis with
Figure 3. BART binds to an active form of Rac1. (A) GST-tagged Rac1 was incubated with GDP or GTPγS and was then used in pull-down
experiments with the recombinant BART protein. Precipitates were examined by Western blot analysis using anti-BART and anti-Rac1
antibodies. Data are representative of three independent experiments. (B) GST-tagged Rac1, a dominant-negative mutated Rac1 form,
Rac1N17, or PAK-CRIB was incubated with S2-013 cell lysates, followed by GST-pull-down assays. Precipitates were examined by West-
ern blot analysis using anti-BART and anti-Rac1 antibodies. Data are representative of three independent experiments. (C) Densitometric
analysis of the results of B. The level of BART in the precipitates was assessed after normalizing BART signals to Rac1 signals. (D) S2-013
cells were pretreated with or without the Rac1 inhibitor (NSC23766) and were immunocytochemically stained using anti-BART (green) and
anti-Rac1 (red) antibodies. Arrows indicate colocalized BART and Rac1 in lamellipodial-like protrusions; blue, DAPI staining. Bars, 10 μm.
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anti-BART and anti-Rac1 antibodies. The CRIB motif has been found
only in effectors for Rac1 but not in RhoGAPs [21]. The interaction of
GST-tagged CRIB with endogenous BART in S2-013 cells through
GTP-bound Rac1 was significantly higher than that of wild-type
Rac1 or Rac1N17. In the immunocytochemical analysis of S2-013
cells, BART and Rac1 colocalized in lamellipodial-like protrusions in
the absence of treatment with the Rac1 inhibitor NSC23766 (arrows
in Figure 3D). Treatment of S2-013 cells with NSC23766 led to inhib-
ition of membrane ruffling and decreased the binding of BART with
Rac1 (Figure 3D). These results suggest that BART preferentially binds
to the active GTP-Rac1 in cell protrusions.
BART Has GAP Activity toward Rac1
To investigate the functional link between BART and Rac1, we
assessed the effect of BART on the regulation of Rac1 activity using
BART RNAi-S2-013 cells that expressed the BART-rescue construct.
Expression of this construct was confirmed by Western blot analysis
(Figure 4A). The increased activity of Rac1 that resulted from BART
knockdown was significantly abrogated by overexpression of BART
in BART RNAi clones. This result confirmed the data shown in
Figure 1A. We therefore hypothesized that Rac1 might be a direct sub-
strate of BART. RhoGAPs stimulate the low intrinsic GTPase activity
of Rho GTPase proteins, leading to conversion of GTP-bound active
forms of Rho GTPases to GDP-bound inactive forms. To determine
whether BART has GAP function toward Rac1, we performed in vitro
GAP assays using the recombinant BART protein (Figure 4B). We pre-
viously demonstrated that ARL2 markedly increased the GTPase activ-
ity of RhoA by using this system [5]. Recombinant BART and human
Rac1 GTPase were incubated with or without the human p50 Rho-
GAP protein. The GAP domain of p50 RhoGAP is known to stimulate
the GTPase activities of Rac1 in vitro. In these studies, BART signifi-
cantly increased the GTPase activity of Rac1 to the same extent as p50
RhoGAP, but this effect of BART was not associated with an effect on
the GAP activity of p50 RhoGAP toward Rac1 (Figure 4B ). These
results suggest that BART plays a role in inactivating Rac1 by acting
as a GAP toward Rac1 and that Rac1 may be a preferred substrate
of BART.
BART Inhibits the Translocation of Rac1 to the
Plasma Membrane
Like other members of the Ras small GTPase family, Rho proteins
function as molecular switches that transduce extracellular stimuli into
intracellular responses and that cycle between a soluble, GDP-bound
inactive state and a membrane-associated GTP-bound active state
[22]. We analyzed the subcellular distribution of Rac1 in BART RNAi
S2-013 cells cultured on fibronectin after transfection of the BART-
rescue construct. Adhesion of cells to fibronectin induces the assembly
of focal adhesion complexes that are linked to the actin cytoskeleton
[23]. Rac1 is known to contribute to the regulation of corneal epithelial
cell adhesion or migration on fibronectin [24]. We found that trans-
fection of a BART-rescue construct inhibited fibronectin-stimulated
Rac1 activation in BARTRNAi cells (Figure 5A). Because translocation
of Rac1 from the cytosol to the cytoplasmicmembrane is required for its
activation and functions, the effect of BART on Rac1 membrane trans-
location was investigated by analyzing subcellular fractionations of
BART RNAi S2-013 cells transfected with the BART-rescue construct
and cultured on fibronectin (Figure 5B ). Transfection of the BART-
rescue construct significantly reduced fibronectin-stimulated Rac1 in
the particulate fraction of the BART RNAi cells. Incubation on fibro-
nectin did not increase active Rac1 in the particulate fraction of the
control cells, and control cells transfected with the BART-rescue con-
struct did not show any significant changes (Figure 5B). Immuno-
cytochemical analysis showed that Rac1 was translocated to the plasma
membrane in BART RNAi cells, whereas in cells expressing the BART-
rescue construct, Rac1 was mainly located in the cytoplasm and only a
little Rac1 was seen at the cell membrane (Figure 5C). After transfection
with the mock plasmid, Rac1 was more abundantly expressed in the
cytoplasm of control cells than the BART RNAi cells, and the
BART-rescue construct did not change the intracellular localization
of Rac1 (Figure 5C ). Accordingly, these results provide supportive
Figure 4. BART has GAP activity toward Rac1. (A) The BART-rescue construct was transfected into control and BART knockdown cells of
S2-013, and 48 hours later, the amount of active GTP-loaded Rac1 was determined by GST-pull-down assays using GST-PAK-CRIB.
Precipitates were examined by Western blot analysis using an anti-Rac1 antibody. Data are representative of three independent experi-
ments. Closed arrowhead indicates exogenous BART; open arrowhead, endogenous BART. (B) The possibility that BART might have a
GAP function for Rac1 GTPase was assayed by in vitro GAP assays using human Rac1 with or without the human p50 RhoGAP protein
together with recombinant BART protein. GST was used as a negative control for RhoGAP and BART protein. GAP activity was assayed
by measurement of the phosphate generated by hydrolysis of GTP. Data are representative of three independent experiments and are
shown as means ± SEM. *P < .005 compared with their respective controls.
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Figure 5. BART inhibits the translocation of Rac1 to the plasma membrane. (A) The mock control vector or myc-tagged BART-rescue
construct was transfected into BART knockdown cells of S2-013, and 48 hours later, the cells were incubated on fibronectin for 1 hour.
GST-pull-down assays were performed using GST-PAK-CRIB. The precipitates were immunoblotted with anti-myc and anti-Rac1 anti-
bodies. Data are representative of three independent experiments. (B) Control (Neo-1 and Scr-1) and BART RNAi (siBART-1 and 2) S2-013
cells treated as in A were fractionated, and particulate/membranous (p) and soluble/cytosolic (s) fractions were analyzed by Western blot
using anti-Rac1 antibody. Asterisk indicates fibronectin-stimulated Rac1 in the particulate fraction of BART RNAi cells. Data are repre-
sentative of three independent experiments. (C) Scrambled control (Scr-1) and BART RNAi (siBART-1) S2-013 cells treated as in A were
immunocytochemically stained using anti-Rac1 (green) and anti-myc (red) antibodies. Blue indicates DAPI staining. The corresponding
differential interference contrast (DIC) images are shown. Bars, 10 μm.
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Figure 6. BART inhibits membrane lamellipodial formation by inhibiting peripheral actin-cytoskeletal rearrangements. (A) Scrambled control
(Scr-1) and BART knockdown (siBART-1) S2-013 cells were incubated on fibronectin for 1 hour, and then actin was immunocytochemically
stained using phalloidin (red) (left panels). Blue indicates DAPI staining. The corresponding DIC images are shown. Bars, 10 μm. Western
blot with anti-BART antibody showing the siBART-1 cells compared with the control Scr-1 cells incubated on fibronectin (right panels).
(B) Quantification of data shown in A; the values represent the number of scrambled control and BART knockdown S2-013 cells with
lamellipodial protrusion. Cells in four fields per group were counted. Data are representative of three independent experiments. Bars,
SD; columns, mean. *P < .005 compared with control cells. (C) BART RNAi S2-013 cells (siBART-1) were pretreated with or without
the Rac1 inhibitor (NSC23766) and then incubated on fibronectin for 1 hour. The cells were immunocytochemically stained using anti-
Rac1 antibody (green), and cellular actin was then stained using phalloidin (red). Blue indicates DAPI staining. Bars, 10 μm. (D) The mock
control vector or BART-rescue construct was transfected into BART knockdown S2-013 cells (siBART-1), and 48 hours later, the cells were
incubated on fibronectin for 1 hour. The cells were immunocytochemically stained using anti-myc antibody (green), and cellular actin was
then stained using phalloidin (red). Blue indicates DAPI staining. The corresponding DIC images are shown. Bars, 10 μm.
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evidence that BART decreases active Rac1 and thereby inhibits the
translocation of Rac1 to the plasma membrane.
BART Inhibits Peripheral Cytoskeletal Rearrangements
of Actin
Rac1, Cdc42, and RhoA are important regulators of actin dynamics
and cell-substratum adhesions in migratory cells and thus are critically
involved in cell motility and invasion [25]. When cells that are initially
suspended adhere to an immobilized fibronectin substrate, a temporal
wave of Rac1 activation is induced, which correlates with the initial
membrane protrusion observed during spreading [26]. Cell shrinkage–
induced activation of Rac1 results in the de novo formation of actin
patches at the cell periphery [27,28]. We analyzed peripheral F-actin
structures in membrane ruffles at the edge of lamellipodia of control
and BART RNAi S2-013 cells cultured on fibronectin (Figure 6, A
and B). Suppression of BART induced fibronectin-mediated membrane
ruffles and lamellipodial protrusions in S2-013 cells. To evaluate the
ability of Rac1 to induce such membrane ruffles, we next examined
the actin cytoskeleton structures of BART RNAi S2-013 cells on fibro-
nectin in the absence or presence of the Rac1 inhibitor NSC23766
(Figure 6C ). Suppression of BART induced surface rearrangements
of the actin cytoskeleton, and NSC23766 inhibited these surface actin
rearrangements that were stimulated by suppression of BART. In
addition, transfection of the BART-rescue construct into BART RNAi
S2-013 cells also reduced these peripheral actin rearrangements
(Figure 6D). These results indicate that BART plays a role in inhib-
iting peripheral actin-cytoskeletal rearrangements through decreasing
active Rac1.
Discussion
PDAC is one of the deadliest cancers owing to its ability to exten-
sively invade surrounding tissues and metastasize at an early stage
[29]. Extensive local infiltration and metastasis are the main causes
of death in PDAC [30]. Here, we report a novel function for BART
in the regulation of cell migration in PDAC. The invasive activity of
stably BART siRNA-transfected PDAC cells was inhibited by pre-
treatment with the specific Rac1 inhibitor NSC23766 in vitro (Fig-
ure 1, C and D). The decreased activity of Rac1 inhibits cell invasion
and is required for the anti-invasive activity of BART.
We previously reported that BART increases active RhoA by inhib-
iting ARL2 function, which, in turn, inhibits the invasive activity of
cancer cells [5]. The BART-ARL2 complex interacts with RhoA;
ARL2, and not BART, possesses GAP activity toward RhoA [5].
However, ARL2 did not interact with the BART-Rac1 complex (data
not shown). BART directly interacts with GTP-bound Rac1 (Fig-
ure 3, A-D ) to decrease Rac1 activity (Figure 4B ), indicating that
BART does not require ARL2 association to regulate Rac1 activity.
Our data suggest that BART inactivates Rac1 by acting as a GAP,
and that Rac1 may be a preferred substrate for BART. It is hypothe-
sized that the active sites of many different GAPs contain an arginine
finger [31]. ARL2, which has a conserved arginine residue, regulates
the tubulin-GAP activity of cofactors C and D, which, in turn, affects
microtubule stability [32]. Because no GTPase activity–triggering
arginine finger residue has been found in BART, further studies are
needed to determine the structure and binding site of BART for the
active forms of Rac1; this will enable understanding of the mechanism
by which the BART-Rac1 complex, which is essential for cell migra-
tion, is formed at the leading edge of migrating cells.
Several lines of evidence indicate that Rac1 may play critical roles in
several aspects of tumorigenesis and cancer progression. Loss of func-
tion of PTEN, p19Arf, or the p53 tumor suppressor leads to elevation
of Rac1 activity, resulting in increased migration and proliferation in
PTEN −/−, p19Arf−/−, or p53−/− cells [33–35]. K-ras is mutated to an
oncogenic, active GTPase form in most PDAC, and K-ras is known to
signal through Rac1 in some cell types [36]. Unlike Ras, however,
constitutively active mutation of Rac1 has not been found in human
cancer [15]. Rho GTPases function as molecular switches that shuttle
between an active GTP-bound state and an inactive GDP-bound
state, which can form a complex with GDI (guanosine nucleotide
dissociation inhibitor) proteins [37]. GTPase activation requires dis-
sociation from GDIs and exchange of GDP for GTP and is catalyzed
by guanosine nucleotide exchange factors that are activated by upstream
signaling events [38]. Therefore, the signaling step of Rac1 activation
by a guanosine nucleotide exchange factor could be a target site of
signaling cascades that involve Rac1. GTPases are turned off by intrin-
sic GTP hydrolysis, which is enhanced by interaction with GAPs [38].
We found that BART directly stimulates the GTPase activity of Rac1
(Figure 4B ), which, in turn, constitutively inactivates Rac1 (Figures 4A
and 5, A-C ). Our data suggest that the GAP activity of BART plays
important roles in maintaining Rac1 in a constitutively inactive state
and in the suppression of the malignant phenotype.
Dynamic actin remodeling processes at the leading edge of migrat-
ing cells are complex and involve increased actin filament severing,
capping, and dendritic branching [39]. Rho GTPases and their effec-
tors are key intracellular signaling molecules that coordinate cyto-
skeletal remodeling that is required for cell spreading, motility, and
cell shape changes [40]. The results of our immunofluorescence stud-
ies show that knockdown of BART induces peripheral rearrangements
of the actin cytoskeleton in S2-013 cells culturedon fibronectin (Figure 6,
A andB), and that exogenously overexpressed BART significantly inhib-
ited peripheral actin-cytoskeletal rearrangements in BART RNAi cells
(Figure 6D). Dynamic, actin-based plasma membrane protrusions that
control growth cone path finding include lamellipodia, in which the
actin cytoskeleton assumes a crosslinked and branched meshwork, and
filopodia, which consist of parallel bundles of actin filaments protruding
from the growth cone or lamellipodial margin [41]. Our results indicate
that BART is a physiological inhibitor that elicits actin redistribution,
leading to peripheral actin rearrangements. Interestingly, peripheral
actin rearrangements were not induced when BART RNAi S2-013 cells
plated on fibronectin were treated with the Rac1 inhibitor (Figure 6C ).
Given that BART regulates the level of Rac1 activity as well as peripheral
actin rearrangements, BART must be associated with the regulation of
membrane ruffles, resulting in the inhibition of PDAC cell motility
and invasion.
The findings presented in this study are supportive of the pivotal
roles of BART in the coordinated regulation of cortical actin changes
through the regulation of the level of Rac1 activity. We have estab-
lished the functional significance of the interaction of BART with
active forms of Rac1, which mediates the anti-invasive effect of
BART in PDAC cells.
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Figure W1. BART functions in regulation of the stability of cell-cell contacts in a Rac1-independent manner. (A) S2-013 cells were pre-
treated with or without the Rac1 inhibitor (NSC23766), and immunocytochemical staining was performed using anti–E-cadherin and
anti–β-catenin antibodies (green). Blue indicates DAPI staining. Bars, 10 μm. (B) Representative E-cadherin and β-catenin staining (green)
in scrambled control (Scr-1) and BART RNAi (siBART-1) S2-013 cells. Blue indicates DAPI staining. Bars, 10 μm.
